主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMVT
#1121
Immunovant, Inc. Common Stock
27.730
0
+3.28%
版块:
基础:
利润货币:
日范围
年范围
日变化
+3.28%
每月变动
+3.47%
6个月变化
+44.35%
年变化
+44.35%
前一天收盘价
26.850
0
Open
27.730
0
Bid
Ask
Low
27.730
0
High
27.730
0
交易量
113
市场
股票
医疗保健
IMVT
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
169.86 M
170.92 M
174.32 M
175.28 M
203.53 M
—
Valuation ratios
Enterprise value
3.83 B
2.21 B
2.19 B
2.3 B
4.18 B
10.88 B
Price to earnings ratio
-9.53
-6.26
-5.63
-5.7
-9.49
-27.08
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-11.03
-6.89
-5.91
-5.98
-10.01
-28.79
Price to book ratio
1.81
3.66
1.17
1.18
1.51
7.52
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.26
0.14
0.18
0.22
0.11
0.64
Return on equity %
0.32
0.15
0.2
0.24
0.11
0.7
Return on invested capital %
-5 436.74
-5 278.94
-1 831.81
-1 051.21
-900.63
-9 062.58
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
6.04
11.16
12.32
9.07
15.74
48.29
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.68
0.73
0.69
0.59
0.51
2.52
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
2.55
4.71
3.5
3.01
5.48
16.7
Net current asset value per share
2.81
5.06
3.81
3.3
5.75
17.93
Tangible book value per share
2.4
4.67
3.56
2.99
5.43
16.65
Working capital per share
2.34
4.61
3.5
2.94
5.38
16.44
Book value per share
2.4
4.67
3.56
2.99
5.43
16.65
新闻
Immunovant stock hits 52-week high at 28.32 USD
Indivior Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
Arcutis Biotherapeutics to Report Q4 Earnings: What's in the Cards?
Recursion Pharmaceuticals to Report Q4 Earnings: What's in the Cards?
IMVT Posts Narrower-Than-Expected Q3 Loss, Pipeline in Focus
Immunovant股票创历史新高达27.87美元
Immunovant stock hits all-time high at 27.87 USD
Immunovant, Inc. (IMVT) Q3 2026 Earnings Call Transcript
Immunovant股价跳涨7%,第三季度亏损收窄,优于预期
Immunovant shares jump 7% as Q3 loss narrows, beats estimates
Philip Morris, Biogen, Telenor, and more set to report earnings Friday
Immunovant earnings up next as Graves’ disease optimism builds